NICE-话题@MedSci

#NICE#

226篇内容 | 2625人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1288900, encodeId=71b6128890006, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=英国NICE推荐安斯泰来前列腺癌药物Xtandi用于国家卫生系统, objectType=article, longId=25579, objectId=a864255e9c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a864255e9c2, replyNumber=0, likeNumber=41, createdTime=2013-10-23, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a864255e9c2, moduleTitle=英国NICE推荐安斯泰来前列腺癌药物Xtandi用于国家卫生系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a864255e9c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288899, encodeId=7222128889942, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE最终指导方案仍不推荐Xalkori用于治疗ALK阳性非小细胞肺癌, objectType=article, longId=25138, objectId=454325138e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=454325138e0, replyNumber=0, likeNumber=0, createdTime=2013-10-01, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=454325138e0, moduleTitle=NICE最终指导方案仍不推荐Xalkori用于治疗ALK阳性非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=454325138e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288898, encodeId=3e0e128889893, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE指南中不推荐克唑替尼治疗NSCLC, objectType=article, longId=23288, objectId=051c232889b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=051c232889b, replyNumber=0, likeNumber=41, createdTime=2013-08-25, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=051c232889b, moduleTitle=NICE指南中不推荐克唑替尼治疗NSCLC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=051c232889b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288897, encodeId=d6a9128889e0a, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE拒绝推荐威罗菲尼治疗黑色素瘤, objectType=article, longId=7275, objectId=a4c2e2758e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4c2e2758e, replyNumber=0, likeNumber=31, createdTime=2012-06-22, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4c2e2758e, moduleTitle=NICE拒绝推荐威罗菲尼治疗黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4c2e2758e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288896, encodeId=0d601288896e9, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE指南草案不推荐贝伐珠单抗/卡培他滨治疗乳腺癌, objectType=article, longId=5675, objectId=80c556e5f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80c556e5f1, replyNumber=0, likeNumber=28, createdTime=2012-04-22, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80c556e5f1, moduleTitle=NICE指南草案不推荐贝伐珠单抗/卡培他滨治疗乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80c556e5f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288895, encodeId=c79d1288895d4, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=拜耳公司抗凝血药物Xarelto获英国NICE推荐, objectType=article, longId=5409, objectId=fe305409c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe305409c3, replyNumber=0, likeNumber=38, createdTime=2012-04-18, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe305409c3, moduleTitle=拜耳公司抗凝血药物Xarelto获英国NICE推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe305409c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1288894, encodeId=738f128889496, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2011版《肺癌诊断及治疗指南》(NICE指南)发布, objectType=article, longId=2566, objectId=766c25663d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=766c25663d, replyNumber=0, likeNumber=37, createdTime=2011-05-08, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=766c25663d, moduleTitle=2011版《肺癌诊断及治疗指南》(NICE指南)发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=766c25663d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NICE

2020-05-29

fusion (审核中...)

前往app查看评论内容

#NICE#

英国NICE推荐安斯泰来前列腺癌药物Xtandi用于国家卫生系统

2013-10-23

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE最终指导方案仍不推荐Xalkori用于治疗ALK阳性非小细胞肺癌

2013-10-01

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE指南中不推荐克唑替尼治疗NSCLC

2013-08-25

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE拒绝推荐威罗菲尼治疗黑色素瘤

2012-06-22

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE指南草案不推荐贝伐珠单抗/卡培他滨治疗乳腺癌

2012-04-22

fusion (审核中...)

前往app查看评论内容

#NICE#

拜耳公司抗凝血药物Xarelto获英国NICE推荐

2012-04-18

fusion (审核中...)

前往app查看评论内容

#NICE#

2011版《肺癌诊断及治疗指南》(NICE指南)发布

2011-05-08

科室
- - 订阅+
  - 更多科室
工具
服务